BSEInsider Trading / SAST2h ago · 25 Sept 2026, 04:32 pm
We would like to inform you that the Trading Window of the Company shall remain closed for the Directors and Designated Employees from October 1, 2026 until 48 hours from the publication of the unaudited financial results for the quarter and half year ended September 30, 2026.
Procter & Gamble Health Ltd · 500126
✦ AI SummaryMgmt Change
Procter & Gamble Health Ltd announces closure of trading window for directors and designated employees from October 1, 2026, until 48 hours after unaudited financial results for Q2FY27 are published.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Procter & Gamble Health Ltd - 500126 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
91be3744-7153-4410-972d-c5b6c3718981.pdf
View document text
Business Use
Date : September 25, 2026
To, To,
The Corporate Relations Department The Listing Department
The BSE Limited The National Stock Exchange of India Limited
Department of Corporate Services Exchange Plaza, Plot No. C/1, G Block,
Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (East),
Dalal Street, Mumbai – 400001 Mumbai – 400051
Ref:- Scrip ID: - 500126 Ref:- Scrip Code:- PGHL
Dear Sir / Madam,
Sub: Intimation of closure of Trading Window
We would like to inform you that the Trading Window of the Company shall remain closed for
Directors and Designated Employees from October 1, 2026 until 48 hours from the publication of the
unaudited financial results for the quarter and half year ended September 30, 2026.
Kindly take the same on record.
Thanking you,
Yours faithfully,
For Procter & Gamble Health Limited
Flavia Machado
Authorized Signatory